The medical technology company, Ypsomed continues to expand its Insulin pen production in Solothurn. This is creating 40 new, full-time, as the company announced on Tuesday.
A major customer to increase his future production quantities of injection systems, it was said to the grounds. The Expansion in production mean an "additional stable revenue contribution".
in Addition, around 110 jobs from the headquarters in Burgdorf and Solothurn will be moved. It was mainly employees from the areas of product management, Mechanics, hardware and software development, logistics, Regulation, the nature and quality management, said in a statement.
Ypsomed has, according to the information in Solothurn, several office buildings, which were rented out until the beginning of the year foreign. This office space would now be occupied by Ypsomed itself. Total Ypsomed currently employs 1'604 persons, 1'089 in Switzerland. It is planned to create in the coming three years, a total of 300 new jobs in Switzerland, both at the site in Solothurn, as well as at the headquarters in Burgdorf.
Created: 30.04.2019, 07:48 PM